Guggenheim Capital LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Guggenheim Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $573,860 - $2.38 Million	-2,049,501 Reduced 93.16%	150,465 $49,000
Q1 2024 May 14, 2024	BUY	$1.06 - $1.67 $2.1 Million - $3.31 Million	1,980,932 Added 904.39%	2,199,966 $2.55 Million
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $5,436 - $7,723	-4,315 Reduced 1.93%	219,034 $370,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $170,428 - $268,874	105,856 Added 90.1%	223,349 $404,000
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.95 $59,028 - $100,969	51,779 Added 78.79%	117,493 $218,000
Q1 2023 May 10, 2023	BUY	$1.2 - $2.19 $78,856 - $143,913	65,714 New	65,714 $87,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.